GlassScriptPhysician profile
Linda A Smith
NPI 1932111895
$3,829.14
in general payments reported to CMS, 2019-2025
21 companies · $911 in 2025
The $911 reported for 2025 was more than what a typical Surgery provider received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $47.54 · 2021: $239 · 2022: $327 · 2023: $950 · 2024: $1,354 · 2025: $911.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,215.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,215.49 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $714.41 | 2021-2025 | Wegovy, Ozempic |
| Astrazeneca Pharmaceuticals LP | $659.79 | 2023-2025 | Airsupra, Breztri, Farxiga |
| Glaxosmithkline, LLC. | $369.99 | 2024-2025 | Penmenvy, Bexsero, Arexvy |
| Lilly USA, LLC | $294.20 | 2024-2025 | Mounjaro, Zepbound |
| Otsuka America Pharmaceutical, INC. | $245.29 | 2023-2025 | Rexulti |
| Amgen INC. | $240.88 | 2023 | Repatha, Otezla |
| Abbvie INC. | $214.70 | 2023 | Vraylar, Qulipta, Ubrelvy |
| Phathom Pharmaceuticals, INC. | $200.21 | 2024-2025 | Voquezna |
| Novartis Pharmaceuticals Corporation | $137.40 | 2023 | |
| Blue Earth Diagnostics | $123.14 | 2024 | |
| Idorsia Pharmaceuticals US INC | $121.36 | 2022 | |
| Janssen Pharmaceuticals, INC | $120.63 | 2024 | Xarelto |
| Abiomed | $113.24 | 2024 | Impella |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $84.93 | 2024 | Lifevest |
| Endomagnetics LTD | $68.27 | 2022 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Focal Therapeutics, INC. | $25.00 | 2019 | |
| Ethicon US, LLC | $22.54 | 2019 | |
| Sirius Medical Systems | $22.33 | 2023 | Pintuition |
| Tempus Ai, INC | $19.64 | 2025 | Xt Cdx |
| Merit Medical Systems INC | $17.60 | 2021 | |
| Tactile Systems Technology INC | $13.59 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Linda Smith listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.